Upregulated COL5A1 indicated poor prognosis in breast cancer, clear cell renal cell carcinoma, lung adenocarcinoma and tongue squamous cell carcinoma 56-59. This evidence concerns the gene COL5A1 and tongue squamous cell carcinoma.